Skip to main content
Signal8

Grosswald Ralph

SEC insider (Form 3/4/5 filer). CIK 0001826084. SVP OF OPERATIONS at Dogwood Therapeutics, Inc. (DWTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 5, 2026. Located in ALPHARETTA, GA.

Companies Grosswald Ralph has filed insider reports for

  • Dogwood Therapeutics, Inc. (DWTX): Officer, SVP OF OPERATIONS
Grosswald Ralph profile photo

Grosswald Ralph

CIK: 0001826084

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Dogwood Therapeutics, Inc. logo
DWTX

Dogwood Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Dogwood Therapeutics, Inc. logo
    DWTX

    Dogwood Therapeutics, Inc.

    Mar 5, 2026
    Award

    Stock Option (right to buy)

    Direct
    82.5K shares-
  • Dogwood Therapeutics, Inc. logo
    DWTX

    Dogwood Therapeutics, Inc.

    Dec 4, 2025
    Award

    Stock Option (right to buy)

    Direct
    150K shares-
  • Dogwood Therapeutics, Inc. logo
    DWTX

    Dogwood Therapeutics, Inc.

    Jun 27, 2025
    Award

    Stock Option (right to buy)

    Direct
    12.1K shares-

1-3 of 3